Photo: Breno Esaki / Agncia Saide-DF
The director of the CDCs (US Centers for Disease Control and Prevention), Rochelle Walenski, suggested this Thursday (16) that people should choose the Pfizer or Modern vaccines as booster doses against Kovit, rather than the Jansen vaccine. (Linked to Johnson & Johnson), the Washington Post said.
According to Valensky, who endorsed the unanimous recommendation of the CDC Advisory Board, there is a higher risk of life-threatening thrombosis associated with Janssen’s single-dose vaccines.
“Today’s updated recommendation underscores CDC’s commitment to providing real – time scientific information to the American people.”, The director said in a note, in which he encouraged Americans to get vaccinated and get encouragement.
As of September, nine deaths (seven women and two men) were confirmed in the country to be related to the problem of thrombosis. Of these patients, seven were between the ages of 28 and 62 and had diseases such as obesity, hypertension, and diabetes.
This news is the latest blow to Johnson & Johnson, whose single-dose vaccine does not require special storage. Reports of low comparative efficacy of the vaccine, as well as the rare coagulation problem, show that vaccine use was very low in the United States, with approximately 17 million doses used, compared to 470 million for Pfizer and Moderna.
“Music geek. Coffee lover. Devoted food scholar. Web buff. Passionate internet guru.”